Reports
Sale
Global Fertility Test Market Size, Share, Trends, Forecast: By Products: Ovulation Predictor Kits, Fertility Monitors; By Application: Male, Female; By End User: Home Care, Fertility Clinics, Hospitals; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Model, Key Demand Indicators; Supplier Landscape; 2024-2032
Global Fertility Test Market Outlook
The global fertility test market size was valued at USD 583.9 million in 2023, driven by the increasing prevalence of infertility across the globe. The market is expected to grow at a CAGR of 7.6% during the forecast period of 2024-2032, with the values likely to rise from USD 628 million in 2024 to USD 1124.2 million by 2032.
Fertility Test: Introduction
Fertility testing is used to identify the issues that might be preventing a couple from conceiving. Fertility tests are available for males as well as females. It constitutes blood tests, pelvic examination, seme analysis, post-coital tests, laparoscopy, and hysteroscopy among others. It is often considered as an initial step to treat infertility and helps in comprehending the couple’s medical history better, enabling customised treatment for their specific condition.
Global Fertility Test Market Analysis
The rising infertility rates, owing to the fast-paced and sedentary lifestyle, and increased drug indulgence, have contributed to the market growth in recent years. The rising emphasis on career often leads to delayed pregnancies and ends up contributing to the growing infertility rates. The rising incidence of diseases like PCOS, PCOD, endometriosis, varicocele, and azoospermia is a key factor aiding the fertility test market growth.
With increasing advancements in the medical ecosystem, fertility tests have evolved over the period. Everything from hormonal tests to imaging tests is available to the masses nowadays. Owing to the rising popularity of self-diagnostic tests and telemedicine, at-home fertility tests are the latest addition to the market. Rising initiatives by various leading companies and the government is also supporting the fertility test market demand.
To combat the rising burden of male infertility, researchers have been looking into new methods of diagnosis for effective treatments. In June 2023, scientists discovered two specific proteins, unique to viable sperm. These ASPX and AKAP4 proteins help in the analysis of whether surgery for non-obstructive azoospermia would be successful or not. This diagnostic test also aligns with the non-invasive approach and enables better decision-making in healthcare professionals.
Global Fertility Test Market Segmentation
Market Breakup by Products
- Ovulation Predictor Kits
- Fertility Monitors
- Urine
- Saliva
- Blood
Market Breakup by Application
- Male
- Female
Market Breakup by End User
- Home Care
- Fertility Clinics
- Hospitals
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Fertility Test Market Overview
Infertility affects 1 in every 6 people on the planet. It is noteworthy that the high-income countries have a higher infertility prevalence (around 17.8%), than low- and middle-income countries where it is approximately 16.5%. Consequently, the North American region, particularly United States and Canada have led the fertility test market share in the historical period. The changing lifestyles, delayed pregnancies, and increased substance consumption have also contributed to the rising market size.
Europe also holds a significant part of the fertility tests market owing to the region’s advanced healthcare system and rising awareness around fertility associated concerns spread by government as well as influential healthcare companies. The innovation and adoption of new technologies to combat the rising incidence of diseases such as PCOS, azoospermia, and endometriosis, among others is contributing to market growth.
Countries like China, Japan, India, and South Korea have been experiencing high growth in the market. Improving healthcare facilities, rising fertility awareness, evolving societal norms, and increasing disposable incomes are impacting the market value.
Global Fertility Test Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Swiss Precision Diagnostics
- Church & Dwight Co., Inc.
- Prestige Brands Holdings
- bioZhena
- Fairhaven Health
- Fertility Focus
- Geratherm Medical AG
- Hilin Life Products
- UEBE Medical
- Churchill Pharmaceuticals, LLC.
- Procter & Gamble Co.
- Mankind Pharma Ltd.
- Babystart Ltd.
- Innevation Pty Ltd.
- AdvaCare Pharma
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Fertility Test Market Overview
3.1 Global Fertility Test Market Historical Value (2017-2023)
3.2 Global Fertility Test Market Forecast Value (2024-2032)
4 Global Fertility Test Market Landscape
4.1 Fertility Test: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Fertility Test: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Fertility Test Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Fertility Test Market Segmentation
6.1 Global Fertility Test Market by Products
6.1.1 Market Overview
6.1.2 Ovulation Predictor Kits
6.1.3 Fertility Monitors
6.1.3.1 Urine
6.1.3.2 Saliva
6.1.3.3 Blood
6.2 Global Fertility Test Market by Application
6.2.1 Market Overview
6.2.2 Male
6.2.3 Female
6.3 Global Fertility Test Market by End User
6.3.1 Market Overview
6.3.2 Home Care
6.3.3 Fertility Clinics
6.3.4 Hospitals
6.4 Global Fertility Test Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Fertility Test Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Fertility Test Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Fertility Test Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Fertility Test Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Fertility Test Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Swiss Precision Diagnostics
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Church & Dwight Co., Inc.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Prestige Brands Holdings
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 bioZhena
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Fairhaven Health
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Fertility Focus
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Geratherm Medical AG
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Hilin Life Products
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 UEBE Medical
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Churchill Pharmaceuticals, LLC.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Procter & Gamble Co.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Mankind Pharma Ltd.
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 Babystart Ltd.
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Innevation Pty Ltd.
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 AdvaCare Pharma
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 583.9 million in 2023, driven by the rising prevalence of infertility across the globe.
The market is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032, likely to reach a market value of USD 1124.2 million by 2032.
The market demand is driven by the increasing number of delayed pregnancies, along with the increasing incidence of conditions like PCOS, endometriosis, azoospermia, and varicocele.
The advent of at-home fertility test kits is a major market trend. 2San launched 4 female fertility tests in July 2023. The company is working on entering the male fertility test market with its new product called SwimCount.
Based on products, the market is divided into ovulation predictor kits and fertility monitors. Fertility monitors are further divided into urine, saliva, and blood.
Major end users include hospitals, home care, and fertility clinics.
It is used in both males and females.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Swiss Precision Diagnostics, Church & Dwight Co., Inc., Prestige Brands Holdings, bioZhena, Fairhaven Health, Fertility Focus, Geratherm Medical AG, Hilin Life Products, UEBE Medical, Churchill Pharmaceuticals, LLC., Procter & Gamble Co., Mankind Pharma Ltd., Babystart Ltd., Innevation Pty Ltd., and AdvaCare Pharma.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER